BLISSGVS.NS
Price:
$171.23
Market Cap:
$18.10B
Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company also provides other healthcare products, such as balms, creams, lotions, lozenges, nasal inhalers, over the counter products, petroleum jellies, powders, roll-ons, shampoos, soaps, solutions, sprays, syru...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2010-07-26
Stock Exchange
NSE
Ticker
BLISSGVS.NS
According to Bliss GVS Pharma Limited’s latest financial reports and current stock price. The company's current PE Ratio is 16.61. This represents a change of 5.44% compared to the average of 15.75 of the last 4 quarters.
The mean historical PE Ratio of Bliss GVS Pharma Limited over the last ten years is 20.66. The current 16.61 PE Ratio has changed 7.94% with respect to the historical average. Over the past ten years (40 quarters), BLISSGVS.NS's PE Ratio was at its highest in in the March 2023 quarter at 55.40. The PE Ratio was at its lowest in in the March 2018 quarter at -35.52.
Average
20.66
Median
15.36
Minimum
10.42
Maximum
52.97
Discovering the peaks and valleys of Bliss GVS Pharma Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 256.92%
Maximum Annual PE Ratio = 52.97
Minimum Annual Increase = -80.32%
Minimum Annual PE Ratio = 10.42
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 15.00 | -6.53% |
| 2024 | 16.05 | 53.99% |
| 2023 | 10.42 | -80.32% |
| 2022 | 52.97 | 256.92% |
| 2021 | 14.84 | 38.91% |
| 2020 | 10.68 | -28.92% |
| 2019 | 15.03 | -56.62% |
| 2018 | 34.65 | 62.82% |
| 2017 | 21.28 | 35.67% |
| 2016 | 15.69 | -29.20% |
The current PE Ratio of Bliss GVS Pharma Limited (BLISSGVS.NS) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
13.83
5-year avg
21.86
10-year avg
20.66
Bliss GVS Pharma Limited’s PE Ratio is greater than Megasoft Limited (10.58), less than Syncom Formulations (India) Limited (19.73), less than Syncom Formulations (India) Limited (19.73), less than Jagsonpal Pharmaceuticals Limited (22.50), less than Bajaj HealthCare Limited (28.91), less than Bajaj HealthCare Limited (28.91), less than Jagsonpal Pharmaceuticals Limited (22.50), less than TTK Healthcare Limited (23.17), less than Hester Biosciences Limited (35.57), less than Hester Biosciences Limited (35.57),
| Company | PE Ratio | Market cap |
|---|---|---|
| 10.58 | $14.72B | |
| 19.73 | $14.20B | |
| 19.73 | $14.23B | |
| 22.50 | $13.98B | |
| 28.91 | $13.22B | |
| 28.91 | $13.25B | |
| 22.50 | $13.90B | |
| 23.17 | $15.35B | |
| 35.57 | $14.07B | |
| 35.57 | $14.03B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bliss GVS Pharma Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bliss GVS Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Bliss GVS Pharma Limited's PE Ratio?
How is the PE Ratio calculated for Bliss GVS Pharma Limited (BLISSGVS.NS)?
What is the highest PE Ratio for Bliss GVS Pharma Limited (BLISSGVS.NS)?
What is the 3-year average PE Ratio for Bliss GVS Pharma Limited (BLISSGVS.NS)?
What is the 5-year average PE Ratio for Bliss GVS Pharma Limited (BLISSGVS.NS)?
How does the current PE Ratio for Bliss GVS Pharma Limited (BLISSGVS.NS) compare to its historical average?